-
1 Comment
PolyNovo Limited is currently in a long term downtrend where the price is trading 15.2% below its 200 day moving average.
From a valuation standpoint, the stock is 70.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 76.9.
PolyNovo Limited's total revenue rose by 25.3% to $13M since the same quarter in the previous year.
Its net income has dropped by 46.3% to $-4M since the same quarter in the previous year.
Finally, its free cash flow grew by 58.9% to $-2M since the same quarter in the previous year.
Based on the above factors, PolyNovo Limited gets an overall score of 3/5.
| Sector | Healthcare |
|---|---|
| Industry | Medical Devices |
| Exchange | AU |
| CurrencyCode | AUD |
| ISIN | AU000000PNV0 |
| Beta | 1.69 |
|---|---|
| Market Cap | 884M |
| PE Ratio | 128.0 |
| Target Price | 2.0131 |
| Dividend Yield | None |
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal scaffold for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MTX for single stage grafting in burns, chronic, and surgical wounds; and plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for PNV.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
